Quarterly report [Sections 13 or 15(d)]

Supplemental Information (Tables)

v3.25.1
Supplemental Information (Tables)
3 Months Ended
Mar. 31, 2025
Product Information [Line Items]  
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following table sets forth common stock equivalents that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been anti-dilutive:

 

 

 

March 31,

 

 

 

2025

 

 

2024

 

Options

 

 

2,190

 

 

 

13,011

 

Restricted stock units

 

 

35,420

 

 

 

78,387

 

Total

 

 

37,610

 

 

 

91,398

 

Accounts Receivable [Member]  
Product Information [Line Items]  
Schedule of Concentration of Credit Risk of Accounts Receivable

Collateral is not required for accounts receivable, and we believe the carrying value approximates fair value. The following table sets forth our concentration of accounts receivable, net of specific allowances for credit losses.

 

 

 

March 31, 2025

 

December 31, 2024

Customer A

 

17%

 

-%

Customer B

 

17%

 

23%

Customer C

 

17%

 

-%

Customer D

 

15%

 

-%

Customer E

 

-%

 

23%

Customer F

 

4%

 

13%